TSHA
#2126
Taysha Gene Therapies, Inc. - Common Stock
5.7 0 USD
+0.06%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+5.95%
Variación mensual
-2.06%
Variación en los últimos 6 meses
+13.10%
Cambio anual
+115.09%
Cierres anteriores
5.3 8
Open
5.8 2
Mínimo
5.6 9
High
5.8 4
Volumen
1 491
Financials
- Market Capitalization 1.64 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-16.18
Relación precio/flujo de caja
179.93
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2114 |  IMCR Immunocore Holdings plc - American Depositary Shares | 33.48 USD | +3.05% | +0.24% | +15.61% | 0.00% | 1.70 B USD | ||
| 2123 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.50 USD | +2.20% | +9.80% | +29.48% | +144.36% | 1.68 B USD | ||
| 2131 |  GHRS GH Research PLC - Ordinary Shares | 26.78 USD | +5.64% | -0.41% | +26.50% | +89.12% | 1.66 B USD | ||
| 2141 |  VIR Vir Biotechnology, Inc. - Common Stock | 9.50 USD | -2.26% | -7.32% | +8.82% | +58.86% | 1.60 B USD |